Hubbry Logo
Malvern PanalyticalMalvern PanalyticalMain
Open search
Malvern Panalytical
Community hub
Malvern Panalytical
logo
7 pages, 0 posts
0 subscribers
Be the first to start a discussion here.
Be the first to start a discussion here.
Malvern Panalytical
Malvern Panalytical
Malvern Panalytical
View on Wikipedia
from Wikipedia

Malvern Panalytical is a Spectris plc company.[6] The company is a manufacturer and supplier of laboratory analytical instruments.[7][8] It has been influential in the development of the Malvern Correlator,[9] and it remains notable for its work in the advancement of particle sizing technology.[10] The company produces technology for materials analysis and principal instruments designed to measure the size, shape and charge of particles.[11] Additional areas of development include equipment for rheology measurements,[3][12] chemical imaging[13] and chromatography.[14] In 2017, they merged with PANalytical to form Malvern Panalytical Ltd.[15]

Key Information

History

[edit]

Malvern Instruments Ltd. was incorporated in 1971.[14] In 1977, Malvern Instruments was recognised by the Royal Academy of Engineering, jointly with the Royal Signals and Radar Establishment (RSRE), for developing the Malvern Correlator.[6][16] It also received the MacRobert Award for Outstanding Technical Innovation (1977),[6] the Queen's Award for Technological Achievement (1977),[17] the Queen's Award for Export Achievement (1981),[17] and the Queen's Award for Export & Technology (1988).[17]

In 1992, Burnfield acquired Malvern Instruments from Cray Electronics Holdings,[18] and, in 1996, there was the acquisition of A3 Water Solutions GmbH, a Stuttgart-based specialist in the design, marketing, and manufacturing of air and liquid particle counters.[19] In 1997, Malvern was also acquired by the Fairey Aviation Company, and Insitec Inc from Burnfield PLC.[20]

The holding company changed its name to Spectris plc in 2001.[4] In 2003, they acquired Bohlin Instruments Ltd, a Gloucestershire-based manufacturer of rheology and viscosity instruments.[21] They also acquired Spectral Dimensions Inc, a manufacturer of infrared chemical imaging instruments, in 2006.[11] Malvern received the 2006 Queen's Award for International Trade.[22]

Viscotek Corp, manufacturer of chromatographic and laboratory equipment and supplies, was acquired in 2008,[10] as well as Reologica Instruments AB, a Lund-based manufacturer of rheology and viscometry instrumentation, in 2010.[3] Malvern received the 2010 Queen's Award for Innovation.[22] The company was also listed as a 2010 winner of the annual Queen's Awards for Enterprise for its work measuring particles in fluids.[2][23][24]

In 2013, they acquired NanoSight, a Wiltshire-based manufacturer of nanoparticle characterization instruments,[5] and, in 2014, the Northampton-based manufacturer of Thermodynamic analysis instruments, MicroCal Instruments, was acquired from GE Lifesciences.[25]

In 2017, they merged with PANalytical to form Malvern Panalytical Ltd.[15] That same year, Malvern Panalytical released their X-ray fluorescence (XRF) spectrometer Epsilon, which was specifically designed for small spot analysis.[26] In 2018, Malvern Panalytical unveiled Empyrean, the first fully automated multipurpose x-ray diffractometer;[27] Claisse LeDoser-12, an Automatic Dispensing Balance; Morphologi Range, a new morphologically-directed raman spectroscopy system, and Epsilon 4, a benchtop x-ray fluorescence spectrometer.[28]

Malvern Panalytical launched a new partnership with SCOTT Technology Ltd., a supplier of sample preparation equipment, in 2020.[29] Their contract included engineering a fully automated robotic analytical system, incorporating fusion bead sample preparation, implementing X-ray spectrometry instrumentation, and developing thermogravimetric analysis (TGA) equipment.[29] The company also joined partnership with Concept Life Sciences that year.[30] Netzsch acquired Malvern Panalytical’s rheometer product lines in February 2020.[31] In this acquisition, Malvern Panalytical extended Netzsch’s product portfolio by providing Kinexus rotational rheometers and Rosand capillary rheometers.[31] In September 2020, Malvern Panalytical received the Physikalisch-Technische Bundesanstalt (PTB) type approval, as a “full-protection” X-ray instrument, for its Aeris range of benchtop XRD diffractometers.[32]

Business model

[edit]

Malvern Instruments began with a focus on particle sizing.[5] As it grew, this focus changed toward developing a "broad portfolio of analytical solutions".[5] In 2014, the company's CTO expressed the company's focus as "We want to solve analytical bottlenecks".[5]

In order to maintain agility and currency in product development, the company built an isolated internal division, the Bioscience Development Initiative based in Columbia, Maryland, which has an entrepreneurial character and freedom from corporate management constraints; the unit aims to rapidly develop technologies in partnership with scientists and engineers from the pharmaceutical and other industries and academia.[5] This unit focuses on the biopharmaceutical sector, specifically formulation of drug products.[5]

PANalytical originally began in 1948 as a branch of Philips under the name of Philips Analytical, which developed XRF (X-Ray Fluorescence) and XRD (X-Ray Diffraction) equipment.[33][34][35] In 2002, Philips Analytical was officially renamed to PANalytical after Spectris’ acquisition of this x-ray analytical branch.[34] Malvern later merged with PANalytical to become Malvern Panalytical Ltd. in 2017.[15]

Operations

[edit]

As part of the materials analysis sector, Malvern Panalytical derives most of its revenue through sales of a range of particle and material characterisation instruments.[4] These systems have applications across many industries including: pharmaceuticals, life sciences, metallurgy, mining, semiconductors, polymer science, protein science and food production.[7][36][37]

Products

[edit]
Malvern droplet and particle analyser

Full products include:

References

[edit]
[edit]
Revisions and contributorsEdit on WikipediaRead on Wikipedia

Malvern Panalytical

View on Grokipedia
from Grokipedia
Malvern Panalytical is a global leader in analytical instrumentation for materials and life sciences characterization, providing technologies that measure chemical, physical, and structural properties of substances ranging from proteins and polymers to minerals and semiconductors. Formed on January 1, 2017, through the merger of Malvern Instruments (founded in the late 1960s in the UK, with pioneering work in laser diffraction particle sizing since 1970) and PANalytical (tracing its roots to Philips' X-ray innovations in 1919, evolving into a specialist in X-ray diffraction and fluorescence by the mid-20th century), the company operates as a subsidiary of Spectris plc, a FTSE 250 precision instrumentation group. In 2024, Malvern Panalytical expanded through acquisitions of SciAps Inc. (July 2024, adding portable XRF, LIBS, and NIR analyzers) and Micromeritics Instrument Corporation (July 2024, enhancing capabilities in surface area and porosity analysis), integrating these brands to offer a broader portfolio of over 92,000 instruments used worldwide. The company's product lineup includes and shape analyzers, instruments, rheometers, diffractometers (XRD), spectrometers (XRF), biomolecular interaction systems, and near-infrared (NIR) solutions, serving industries such as pharmaceuticals, chemicals, energy, and academia to accelerate R&D and efficiency. With more than 2,500 employees, operations in over 20 countries, and R&D facilities across , , and , Malvern Panalytical emphasizes , targeting Net Zero emissions in its operations by 2030 and across its by 2040.

History

Formation of Predecessor Companies

The company that became Malvern Instruments was founded in 1961 in , , by Derek Stephen Trudgill, Bill Woodley, and Arthur Kitson as Precision Display Systems. It was renamed Malvern Instruments Ltd. in 1971, shifting focus to the development of laser-based technologies for and initially operating from a garden shed. The company quickly established itself as a pioneer in this field, releasing its first laser diffraction instrument in 1976. A key milestone came in 1977 with the launch of the Malvern Correlator, the world's first commercial laser-based analyzer, which revolutionized non-destructive measurement of particle movement using photon correlation spectroscopy, developed in collaboration with the Royal Signals and Radar Establishment. This innovation earned the company the MacRobert Award from the Royal Academy of Engineering and the Queen's Award for in the same year. Further recognition followed with additional Queen's Awards for Technological Achievement in 1981 and 1988, reflecting the company's ongoing advancements in precision measurement instrumentation during the . Through the and , Malvern Instruments expanded its portfolio beyond core particle sizing, incorporating techniques for analysis and laying the groundwork for later developments in related characterization methods. PANalytical traces its origins to the Philips Analytical X-ray division, established in 1948 within the company in the , building on earlier innovations such as the first commercial in 1919 and the inaugural in 1945. Specializing in X-ray diffraction (XRD) and (XRF) technologies, the division advanced materials analysis tools critical for industries including and pharmaceuticals, enabling precise composition and structural characterization of ores, minerals, and drug formulations. In 2002, following its acquisition by plc, the business was rebranded as PANalytical, marking a new phase of independent growth while retaining its expertise in high-performance analytical systems for resource extraction and applications. These predecessor companies' independent histories culminated in their 2017 merger to form Malvern Panalytical, uniting complementary strengths in particle and materials characterization.

Key Mergers and Acquisitions

Malvern Panalytical was formed through the merger of Malvern Instruments Limited, based in Malvern, , and PANalytical B.V., based in Almelo, , both subsidiaries of plc. The merger was announced on November 22, 2016, and completed on January 1, 2017, creating a combined entity with dual headquarters in the UK and Netherlands to enhance synergies in materials and life sciences analytics. Prior to the merger, Malvern Instruments expanded its capabilities through targeted acquisitions. In September 2013, Malvern acquired NanoSight Ltd., a specialist in , for approximately $24 million, which strengthened its offerings in particle characterization for biological and pharmaceutical applications. In July 2014, Malvern completed the acquisition of MicroCal from Life Sciences, adding microcalorimetry technologies for biophysical characterization in . Meanwhile, PANalytical had acquired Corporate Scientific Claisse Inc. in June 2014, integrating Claisse's expertise in for analysis into its portfolio. Following the merger, Malvern Panalytical pursued further strategic acquisitions to broaden its technological reach. In January 2022, the company acquired Creoptix AG, a Swiss firm specializing in biomolecular interaction analysis using waveguide , with integration completed in the first half of the year to enhance early-stage tools. In July 2024, announced the acquisition of SciAps Inc. for up to $260 million, which was completed on August 21, 2024, adding portable laser-induced breakdown spectroscopy and X-ray fluorescence analyzers for real-time . Shortly thereafter, on July 16, 2024, the acquisition of Micromeritics Instrument Corporation was agreed for $630 million plus up to $53 million in deferred consideration, completing on August 23, 2024, and incorporating advanced instruments for and measurement. These have significantly diversified Malvern Panalytical's portfolio, enabling integrated solutions across laboratory and field-based applications. For instance, the integration of SciAps' handheld technologies has expanded capabilities in and sectors by facilitating on-site material analysis without extensive .

Corporate Structure

Ownership and Leadership

Malvern Panalytical functions as a wholly owned and key operating division within Scientific, the Materials Analysis segment of plc, a FTSE 250-listed precision measurement . This structure traces back to ' 2002 acquisition of Analytical, which was rebranded as PANalytical, and the subsequent 2017 merger of PANalytical with Malvern Instruments—both entities under ownership—to form Malvern Panalytical. In July 2025, agreed to a recommended cash acquisition by KKR for approximately £4.7 billion ($6.5 billion), valuing shares at £41.75 each, expected to complete in the first quarter of 2026. Upon completion, Malvern Panalytical will continue as a under the new ownership structure. As of November 2025, Malvern Panalytical is led by President and CEO Terry Kelly, who joined from following its 2024 acquisition by and now oversees the integrated operations. The executive leadership team includes Vice President of Andrea F. Gullà, responsible for R&D integration across recent acquisitions, alongside other key roles such as Director of Operations and Site Lead Michelle Charles and various regional presidents focused on commercial strategy. At the parent level, plc's board as of November 2025 comprises Non-Executive Chairman Mark Williamson, Andrew Heath, Angela Noon, and independent non-executive directors including Kjersti Wiklund and Shân Millard, providing oversight on strategic, financial, and sustainability matters, with changes expected following the KKR acquisition completion. Governance at Malvern Panalytical aligns with ' commitment to high standards of corporate responsibility, including a science-based target for Net Zero emissions in operations (Scopes 1 and 2) by 2030, supported by annual investments of at least £3 million in abatement initiatives. ' 2025 half-year results highlighted robust performance in analytical instruments, with Scientific—encompassing Malvern Panalytical—reporting 21% reported sales growth (3% like-for-like) in the first half, driven by strong demand in particle characterization and integration benefits from acquisitions like and SciAps. The company's global employee base has expanded to over 2,500 by 2025, reflecting growth through strategic acquisitions that bolster its materials analysis capabilities.

Business Model

Malvern Panalytical generates the majority of its revenue through the sale of analytical instruments and related software, accounting for approximately 88% of its 2022 sales, with the remainder derived from services such as maintenance contracts, training, and technical support. This model emphasizes premium, asset-light precision measurement solutions that support research, development, and manufacturing processes across various industries. The company's target markets include pharmaceuticals and life sciences, which contributed 43% of the Spectris Scientific division's sales in 2022 (with Malvern Panalytical as the primary contributor), alongside , and minerals (18%), and semiconductors (16%), academic research (12%), and other sectors like and biopharma. It positions itself by addressing analytical bottlenecks through integrated workflows that combine hardware, software, and to enable efficient material and particle . Following the merger of Malvern Instruments and PANalytical, the company shifted from offering standalone particle sizing tools to providing comprehensive characterization suites that integrate multiple analytical techniques for broader materials analysis. This evolution includes the introduction of subscription-based software options, such as HighScore for phase identification and data treatment, to support ongoing and . In biosciences, Malvern Panalytical has advanced biopharmaceutical applications through its Bioscience Development Initiative center in Columbia, Maryland, which focuses on developing customized biophysical characterization solutions. The company also pursues partnerships, such as with Concept Life Sciences for integrated analytics services and Xenocs for advanced pharmaceutical tools, to deliver tailored solutions in drug discovery and development. Recent acquisitions like Micromeritics in 2024 have further strengthened its porosity analysis capabilities within these initiatives.

Operations

Global Presence

Malvern Panalytical operates with dual headquarters: one in Malvern, , which serves as the primary site for administration and stemming from the original Malvern Instruments legacy, and another in , , representing the PANalytical heritage with a focus on manufacturing. The company maintains manufacturing and R&D facilities in key global locations, including its site in , , which became the first facility to achieve silver certification for in 2024; operations in , acquired through , and ; a Canadian facility via the Claisse brand in ; and additional sites across to support regional production and innovation. Malvern Panalytical's sales and service network extends to over 100 countries through direct offices in 20 nations and a robust distributor system, backed by more than 2,500 employees dedicated to customer support worldwide. Recent acquisitions, including SciAps in the area and in Georgia, have further strengthened the company's footprint in the United States.

Research and Development

Malvern Panalytical allocates a significant portion of its resources to research and development, with its parent company reporting R&D investments representing approximately 8% of sales in 2024 and 7.9% in the first half of 2025. These efforts emphasize the integration of technologies from recent acquisitions, such as AI-driven capabilities from SciAps and advanced particle characterization methods from , to enhance analytical solutions across materials and life sciences. Key R&D initiatives include the development of automated robotic systems for mining applications, exemplified by the 2020 contract with Scott Automation to supply a fully automated analytical laboratory for Rio Tinto's Koodaideri iron ore project in Australia. This project involved engineering and equipment for real-time material analysis, advancing on-site process optimization. Additionally, sustainability-focused innovations feature low-energy X-ray fluorescence (XRF) spectrometers, such as the Revontium launched in 2024, which operates at just 200 watts—compared to 2,000 watts for traditional wavelength-dispersive XRF systems—reducing environmental impact and operational costs. The company fosters collaborations with universities and research labs to drive advancements, including extended partnerships with the University of Twente's XUV Optics Research Group for metrology in 2024 and the University of Pittsburgh's Kumta Lab for battery technology development. In biopharma, the Bioscience Development Initiative, established in 2012, promotes collaborative innovation in characterization techniques to address formulation stability and therapeutic development challenges. Recent outputs include the full integration of SciAps' handheld analyzers into Malvern Panalytical's core portfolio in early 2025, enabling seamless complementary workflows with ' technologies for comprehensive materials analysis. This integration supports distributed R&D across global sites, accelerating innovation in particle and elemental .

Products and Technologies

Particle Characterization

Malvern Panalytical's particle characterization portfolio centers on advanced techniques for determining , shape, and physical properties, essential for optimizing material performance across industries. Core technologies include laser diffraction, (DLS), and image analysis, which enable precise measurements from submicron to millimeter scales. These methods provide critical data on particle distributions, supporting applications in formulation development and process control. Laser diffraction, exemplified by the Mastersizer 3000+ series, measures particle size distributions by analyzing the angular pattern of laser light scattered by particles in suspension or dry dispersion. This technique reports volume-based diameters, where the size is defined as the diameter of an equivalent sphere having the same volume as the particle, calculated using Mie scattering theory that accounts for the optical properties of the sample and dispersant. For instance, key metrics include Dv10, Dv50 (median volume diameter), and Dv90, which quantify the 10th, 50th, and 90th percentiles of the volume distribution, helping assess uniformity in polydisperse samples. The instrument's wet and dry dispersion modules facilitate rapid analysis for powders and suspensions, with measurement times under a minute. Dynamic light scattering, via the Zetasizer Advance range, targets nanoparticles and colloids by detecting fluctuations in scattered light intensity due to , yielding hydrodynamic diameters from 0.3 nm to 10 µm. The polydispersity index (PDI), a dimensionless value derived from cumulants analysis of the autocorrelation function, indicates distribution breadth—values below 0.05 suggest monodispersity, while higher values signal heterogeneity, aiding in stability assessments. Complementing this, the Morphologi 4-ID employs automated image analysis to capture particle shape and composition through high-resolution microscopy and , generating metrics like circularity and for individual particles in the 0.5 µm to 1.5 mm range. These tools together offer orthogonal insights into size and morphology without chemical alteration. Following the 2024 acquisition of , Malvern Panalytical expanded its capabilities with gas adsorption and methods for enhanced surface and density characterization. The 3Flex system performs analysis to determine surface area and using nitrogen or other gases, applying the Brunauer-Emmett-Teller () model for monolayer coverage calculations, which is vital for porous materials like catalysts. techniques, such as those in the Sedigraph series, measure by monitoring settling velocities in a gravitational or centrifugal field, providing density-based distributions that complement light scattering for denser powders. These additions enable a more complete physical profile of particles and powders. In pharmaceuticals, these technologies ensure during drug formulation by verifying distributions that influence dissolution rates and , with laser diffraction routinely used to meet regulatory standards for uniformity. In materials , they optimize flow properties—such as avalanche angle and cohesion—critical for additive manufacturing and processes, where shape analysis from Morphologi 4-ID predicts handling behavior. For example, a narrow volume distribution (low span = (Dv90 - Dv10)/Dv50) correlates with improved flowability in metal powders. Overall, these methods drive by linking particle properties to end-product .

Elemental and Structural Analysis

Malvern Panalytical offers a range of (XRF) spectrometers for non-destructive , enabling the identification and quantification of elements from to in various materials. The Epsilon 4 benchtop energy-dispersive XRF (EDXRF) analyzer provides rapid, multi-element analysis with high repeatability, suitable for applications in , polymers, and . For more precise detection of trace elements, the company employs wavelength-dispersive XRF (WDXRF) systems, such as the Zetium spectrometer, which integrates ED and WD capabilities to achieve superior resolution and sensitivity for light elements and low concentrations. In X-ray diffraction (XRD), Malvern Panalytical's platform serves as a versatile for phase identification and crystallographic structure determination, analyzing materials such as minerals, polymers, and through powder, thin-film, and solid-sample configurations. The system supports non-destructive evaluation of crystal structures, facilitating research in and . Following the 2024 acquisition of SciAps Inc., Malvern Panalytical expanded its portfolio with handheld XRF and analyzers, including the Z-900 series LIBS units, such as the Z-903, which enable on-site for exploration, ore grading, and metal without . These techniques rely on fundamental principles like for interpreting diffraction patterns in XRD, expressed as: nλ=2dsin⁡θn\lambda = 2d \sin\theta where nn is an , λ\lambda is the , dd is the interplanar spacing, and θ\theta is the incidence angle, allowing precise determination of atomic arrangements. Such methods find critical applications in for alloys, where phase composition ensures material integrity, and in cement production, monitoring clinker phases for performance optimization. These and structural tools integrate briefly with particle sizing workflows to provide comprehensive material characterization.

Biophysical Characterization

Malvern Panalytical's biophysical portfolio focuses on label-free techniques for analyzing biomolecular interactions, stability, and structural properties essential to life sciences research. Key instruments include the MicroCal PEAQ-ITC for (ITC), which directly measures the heat changes associated with biomolecular binding events to determine thermodynamic parameters such as binding affinities. This system supports low-volume, high-sensitivity experiments suitable for early-stage , enabling precise of protein-ligand interactions without labels. Complementing ITC, the Creoptix WAVEsystem employs WaveRAPID (SPR) technology to provide real-time kinetic data on biomolecular associations and dissociations, even in complex crude samples like serum, accelerating hit identification and validation in . For and aggregate analysis in biological contexts, the NanoSight range utilizes (NTA) to quantify size distributions and concentrations of extracellular vesicles (EVs), which are critical in cell communication and disease biomarker studies. 's visualization of individual particles offers high-resolution insights into EV heterogeneity, supporting applications in vaccine production and therapeutic delivery systems. The Zetasizer Advance series, through (DLS) and measurements, assesses protein stability and formulation behavior in biopharmaceuticals by detecting aggregation propensity and colloidal interactions. These tools evaluate factors like electrostatic repulsion to predict long-term stability, aiding in the optimization of formulations. In , these technologies enable the measurement of key biophysical parameters, such as dissociation constants (Kd) derived from ITC binding isotherms, which inform lead optimization and efficacy predictions. For vaccine , NTA and Zetasizer instruments facilitate the analysis of viral vectors and lipid nanoparticles, ensuring consistent and stability to meet regulatory standards. Particle tools from Malvern Panalytical further support aggregate detection in biologics workflows, enhancing overall .

References

  1. https://www.malvernpanalytical.com/en/about-us
  2. https://www.malvernpanalytical.com/en/about-us/our-brands/malvern
  3. https://www.malvernpanalytical.com/en/about-us/our-brands/panalytical
  4. https://www.malvernpanalytical.com/en/about-us/press-releases/news/pr240716-micromeritics
  5. https://www.malvernpanalytical.com/en/about-us/press-releases/news/pr240703-sciaps-inc
  6. https://www.spectris.com/newsroom/acquisition-of-micromeritics-instrument-corporation/
  7. https://www.spectris.com/our-group/spectris-scientific/malvern-panalytical/
  8. https://www.malvernpanalytical.com/en/learn/knowledge-center/insights/derek-stephen-trudgill-founder-of-malvern-instruments
  9. https://www.atascientific.com.au/creating-a-world-leading-instrument-company-from-a-garden-shed/
  10. https://www.malvernpanalytical.com/en/learn/knowledge-center/insights/the-malvern-correlator-the-worlds-first-commercial-laser-based-particle-size-analyzer
  11. https://www.rheology.org/sor/Publications/RheoBulletin/RB2008Jul.pdf
  12. https://www.malvernpanalytical.com/en/learn/knowledge-center/insights/x-ray-tubes-for-more-than-half-a-century
  13. https://www.pharmaceutical-business-review.com/suppliers/panalytical-pbr/
  14. https://www.laserfocusworld.com/test-measurement/research/article/16558411/spectris-completes-acquisition-of-philips-analytical
  15. https://www.envirotech-online.com/news/air-monitoring/6/malvern-panalytical-bv/milestone-reached-as-panalytical-celebrates-5th-anniversary/2129
  16. https://www.malvernpanalytical.com/en/about-us/press-releases/news/prmalvernpanalytical
  17. https://www.malvernpanalytical.com/en/about-us/our-brands
  18. https://cen.acs.org/articles/91/i40/Malvern-Acquires-NanoSight.html
  19. https://www.bionity.com/en/news/148244/nanosight-acquired-by-malvern-instruments.html
  20. https://www.prnewswire.com/news-releases/malvern-instruments-completes-acquisition-of-microcal-and-announces-purchase-of-archimedes-product-from-affinity-biosensors-268563732.html
  21. https://www.worldcement.com/the-americas/20062014/Spectris_acquires_Canada_based_Claisse_388/
  22. https://analyticalscience.wiley.com/content/news-do/malvern-panalytical-acquire-creoptix
  23. https://www.spectris.com/assets/Uploads/Results-reports-and-presentations/Spectris-Press-Release-2022-HY-Final.pdf
  24. https://prod-aws.londonstockexchange.com/news-article/SXS/completion-of-the-acquisition-of-sciaps-inc/16629853
  25. https://www.londonstockexchange.com/news-article/SXS/completion-of-the-acquisition-of-micromeritics/16633898
  26. https://www.spectris.com/newsroom/spectris-acquires-sciaps-incorporated/
  27. https://www.adviser-rankings.com/company/1928/spectris-plc/ftse-250/industrials
  28. https://www.reuters.com/world/uk/kkr-agrees-buy-spectris-65-billion-deal-tops-advent-offer-2025-07-02/
  29. https://www.spectris.com/newsroom/2025-half-year-results/
  30. https://craft.co/malvern-panalytical/executives
  31. https://markets.ft.com/data/equities/tearsheet/directors?s=SXS:LSE
  32. https://www.spectris.com/our-story/our-board/
  33. https://www.spectris.com/buiding-a-sustainable-business/environment/
  34. https://www.spectris.com/assets/Uploads/Results-reports-and-presentations/Spectris-AR-2022.pdf
  35. https://www.malvernpanalytical.com/en/about-us/press-releases/news/prtetra
  36. https://mystore.malvernpanalytical.com/mystore/s/en-GB/product/highscore-subscription/01tdP000004YsRtQAK
  37. https://www.news-medical.net/news/20130911/Bioscience-development-an-interview-with-Dr-E-Neil-Lewis-Chief-Technology-Officer-Malvern-Instruments.aspx
  38. https://www.worldpharmatoday.com/news/malvern-panalytical-and-concept-life-sciences-announce-integration-2/
  39. https://www.malvernpanalytical.com/en/about-us/press-releases/news/pr241003-xenocs-collaboration-pharmaceutical-analytics
  40. https://www.spectris.com/assets/FY24-Results-RNS-v-FINAL.pdf
  41. https://www.dekra.nl/en/malvernpanalytical/
  42. https://micromeritics.com/press-release/micromeritics-to-join-malvern-panalytical-to-become-world-leader-in-particle-characterization/
  43. https://www.malvernpanalytical.com/en/about-us/our-brands/claisse
  44. https://www.malvernpanalytical.com/en/about-us/our-brands/asd-inc
  45. https://www.spectris.com/assets/HY25-Results_RNS-statement.pdf
  46. https://www.spectris.com/assets/HY24-full-deck-v-FINAL-updated-pie-charts.pdf
  47. https://www.malvernpanalytical.com/en/about-us/press-releases/news/pr200701scottautomation
  48. https://www.e-mj.com/departments/suppliers-report/malvern-tapped-for-lab-for-rio-tintos-koodaideri/
  49. https://www.selectscience.net/article/malvern-panalytical-launches-revontium-at-analytica-2024
  50. https://www.malvernpanalytical.com/en/products/product-range/revontium
  51. https://www.malvernpanalytical.com/en/about-us/press-releases/news/pr240715-university-twente
  52. https://www.utwente.nl/en/news/2024/7/1646330/x-ray-metrology-for-academia-and-industry
  53. https://www.malvernpanalytical.com/en/learn/knowledge-center/insights/pitts-game-changing-battery-tech-doubling-ev-range-halving-costs
  54. https://www.linkedin.com/posts/sciaps-inc-_integration-of-malvern-panalytical-micromeritics-activity-7301232489576955905-AObf
  55. https://www.malvernpanalytical.com/en/academia/interact-with-us/research-partnerships
  56. https://www.malvernpanalytical.com/en/products/measurement-type/particle-characterization
  57. https://www.malvernpanalytical.com/en/learn/knowledge-center/whitepapers/wp120620basicguidepartchar
  58. https://www.malvernpanalytical.com/en/products/measurement-type/particle-size
  59. https://www.malvernpanalytical.com/en/products/product-range/epsilon-range/epsilon-4
  60. https://www.malvernpanalytical.com/en/products/technology/xray-analysis/x-ray-fluorescence/wavelength-dispersive-x-ray-flourescence
  61. https://cmm.centre.uq.edu.au/malvern-panalytical-zetium-xrf
  62. https://www.malvernpanalytical.com/en/products/product-range/empyrean-range/empyrean
  63. https://www.malvernpanalytical.com/en/products/product-range/z-series/z-903
  64. https://www.malvernpanalytical.com/en/products/product-range/empyrean-range
  65. https://www.malvernpanalytical.com/en/products/category/x-ray-fluorescence-spectrometers
  66. https://www.malvernpanalytical.com/en/products/product-range/microcal-range/microcal-itc-range/microcal-peaq-itc
  67. https://www.malvernpanalytical.com/en/products/product-range/wave
  68. https://www.malvernpanalytical.com/en/products/product-range/wave/accessories/wavecontrol/waverapid
  69. https://www.malvernpanalytical.com/en/industries/biologics/extracellular-vesicles
  70. https://www.malvernpanalytical.com/en/products/product-range/zetasizer-range/zetasizer-advance-range
  71. https://www.malvernpanalytical.com/en/industries/biologics/discovery-early-development
Add your contribution
Related Hubs
User Avatar
No comments yet.